PTK2 and neoplasm: Several studies have reported that activated focal adhesion kinase (FAK) promotes tumor malignancy by affecting the functions of or stimulating morphological changes in tumor cells and stromal cellular components of the TME and correlates with poor prognosis in tumor patients [29, 30].